Dongdong Xie

1.6k citations
71 papers · 1.2k indexed · h-index 18
Topics
Vitamin D Research Studies (8 papers)Kidney Stones and Urolithiasis Treatments (6 papers)Bladder and Urothelial Cancer Treatments (5 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Dongdong Xie

65 papers receiving 1.2k citations

Peers

Dongdong Xie
Comparison fields: 5 of 131
  • Molecular Biology 328
  • Pathology and Forensic Medicine 176
  • Epidemiology 169
  • Physiology 162
  • Oncology 159
Replace Qing Wang with:
Qing Wang China
Xiaoyan Shi China
Eric Schulze‐Bahr Germany
Hyun Joo Shin South Korea
M.R. Pandian United States
Rong Wan China
Hueng‐Chuen Fan Taiwan
Feng Zheng China
Dariusz Kajdaniuk Poland
Dongdong Xie relative to Qing Wang China Qing Wang's profile →
Citations per field
00.5×1.5×
Qing Wang · 1×
Citations per year

Countries citing papers authored by Dongdong Xie

Since Specialization
Citations

This map shows the geographic impact of Dongdong Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongdong Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongdong Xie more than expected).

Fields of papers citing papers by Dongdong Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongdong Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongdong Xie. The network helps show where Dongdong Xie may publish in the future.

Co-authorship network of co-authors of Dongdong Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Dongdong Xie. A scholar is included among the top collaborators of Dongdong Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongdong Xie. Dongdong Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 0
4 1
5 3
6 17
7 13
8 6
9 30
10 7
11 15
12 11
13 41
14 41
15 9
16 11
17 19
18 39
19 55
20
Novel Lipid Signaling Pathway Modulates Corneal Epithelial Proliferation
1

About Dongdong Xie

Dongdong Xie is a scholar working on Urology, Nephrology and Pulmonary and Respiratory Medicine, having authored 71 papers that have together received 1.2k indexed citations. Recurring topics across this work include Vitamin D Research Studies (8 papers), Kidney Stones and Urolithiasis Treatments (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). The work is most often cited by research in Endocrine and Autonomic Systems (140 citations), Orthopedics and Sports Medicine (114 citations) and Pathology and Forensic Medicine (176 citations). Dongdong Xie has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Carlos M. Isales, Mark W. Hamrick, Catherine Pennington, Shen Xu, De‐Xiang Xu, Zhihui Zhang, De‐Xin Yu, Yuan‐Hua Chen, Jianbao Zhang and Xiaolin Yu. Their work appears in journals such as PLoS ONE, Scientific Reports and Small.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026